Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer
2023 · JAMA · 125 citations
https://doi.org/10.1001/jama.2023.7843
T
Thomas Delate
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
203
Papers
4.0K
Citations
33
h-index
87
i10-index
Thomas Delate is an academic researcher from Kaiser Permanente. The author has contributed to research in topics: Atrial Fibrillation Management and Outcomes & Pharmaceutical Practices and Patient Outcomes & Venous Thromboembolism Diagnosis and Management. The author has an h-index of 33, co-authored 173 publications.
ORCID: 0000-0002-6530-8415Papers by this author
worksCommentary on using the SF-36 or MOS-HIV in studies of persons with HIV disease.
2003 · Health and Quality of Life Outcomes · 54 citations
https://doi.org/10.1186/1477-7525-1-25
Effectiveness and safety of direct oral anticoagulants in patients with venous thromboembolism and creatinine clearance < 30 mL/min
2022 · Journal of Thrombosis and Thrombolysis · 6 citations
https://doi.org/10.1007/s11239-022-02758-7
Retrospective assessment of antimicrobial stewardship initiative in outpatient use of ertapenem for uncomplicated extended spectrum beta lactamase Enterobacteriaceae urinary tract infections
2021 · BMC Infectious Diseases · 3 citations
https://doi.org/10.1186/s12879-021-06458-0
Real-World Noninferiority Assessment of Two Filgrastim Biosimilars in Patients Receiving Myelosuppressive Chemotherapy
2024 · JCO Oncology Practice · 2 citations
https://doi.org/10.1200/op.24.00047
Methotrexate fixed dosing protocol for ambulatory treatment of ectopic pregnancy
2025 · Reproductive Sciences · 2 citations
https://doi.org/10.1007/s43032-024-01768-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat